D. Neumeier
Impact in
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Immunology top 5%
- Atherosclerosis and Cardiovascular Diseases
- Immune Response and Inflammation
Papers in
- Immunology 17
- Immune Response and Inflammation 7
- Atherosclerosis and Cardiovascular Diseases 4
-
- NF-κB Signaling Pathways 10
- Co-authors
- Korbinian BrandSharon PageMichael J. PageH BaumChristian KaltschmidtPatrick A. BaeuerleRichard BrandlGerhard Rogler
- Journals
- Journal of Molecular Medicine (7 papers)Clinical Chemistry (7 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (6 papers)Journal of Biological Chemistry (4 papers)Clinica Chimica Acta (4 papers)
- Partner nations
- GermanyAustriaUnited Kingdom
In The Last Decade
D. Neumeier
68 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 528
- Immunology 723
- Cardiology and Cardiovascular Medicine 617
- Immunology and Allergy 150
- Biochemistry 141
Countries citing papers authored by D. Neumeier
This map shows the geographic impact of D. Neumeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Neumeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Neumeier more than expected).
Fields of papers citing papers by D. Neumeier
This network shows the impact of papers produced by D. Neumeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Neumeier. The network helps show where D. Neumeier may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D. Neumeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 55 | |
| 2 | 2004 | 51 | |
| 3 | 2004 | 9 | |
| 4 | 2002 | 30 | |
| 5 | 2002 | 71 | |
| 6 | 2000 | 33 | |
| 7 | 1999 | 66 | |
| 8 | 1998 | 17 | |
| 9 | 1997 | 10 | |
| 10 | 1997 | 143 | |
| 11 | Transcription factor NF-kB/Rel is activated in the atherosclerotic lesion. | 1996 | 11 |
| 12 | Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. Hit paper breakdown → | 1996 | 677 |
| 13 | 1993 | 2 | |
| 14 | 1991 | 4 | |
| 15 | 1991 | 15 | |
| 16 | 1991 | 4 | |
| 17 | 1989 | 12 | |
| 18 | 1989 | 3 | |
| 19 | 1988 | 1 | |
| 20 | [Methodical accomplishment and results of quality control attempts in the CEA determination using a commercial radioimmunoassay kit]. | 1976 | 1 |
About D. Neumeier
D. Neumeier is a scholar working on Immunology, Cancer Research, Cardiology and Cardiovascular Medicine, Rheumatology and Hematology, having authored 71 papers that have together received 2.7k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (10 papers), Immune Response and Inflammation (7 papers), Acute Myocardial Infarction Research (6 papers), Cardiac Imaging and Diagnostics (5 papers), Viral Infections and Immunology Research (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (528 citations), Immunology (723 citations), Cardiology and Cardiovascular Medicine (617 citations), Immunology and Allergy (150 citations) and Biochemistry (141 citations). D. Neumeier has collaborated with scholars based in Germany, Austria and United Kingdom. Frequent co-authors include Korbinian Brand, Sharon Page, Michael J. Page, H Baum, Christian Kaltschmidt, Patrick A. Baeuerle, Richard Brandl, Gerhard Rogler, Andreas Bartsch and Ruth Knuechel. Their work appears in journals such as Journal of Molecular Medicine, Clinical Chemistry, Clinical Chemistry and Laboratory Medicine (CCLM), Journal of Biological Chemistry and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.